London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
You will only have one login account. Registering with multiple accounts is not allowed. Any user found to have more than one account on this site will have all, and any future accounts suspended permanently.
Your email and password must only be used by you. If a post is made under your account, it will be considered that it was posted by yourself.
Your account nickname must not be the same, or contain, listed company names or board members' names.
While debating and discussion is fine, we will not tolerate; rudeness, swearing, insulting posts, personal attacks, or posts which are invasive of another's privacy.
You will not;
discuss illegal or criminal activities.
post any confidential or price sensitive information or that is not public knowledge.
post misleading or false statements regarding the share price and performance. Such posts are deemed as market abuse, and may be reported to the appropriate authorities.
post any private communication, or part thereof, from any other person, including from a member of the board of directors of a listed company. Such posts cannot be verified as true and could be deemed to be misleading.
post any personal details (e.g. email address or phone number).
post live price or level 2 updates.
publish content that is not your original work, or infringes the copyright or other rights of any third party.
post non-constructive, meaningless, one word (or short) non-sense posts.
post links to, or otherwise publish any content containing any form of advertising, promotion for goods and services, spam, or other unsolicited communication.
post any affiliate or referral links, or post anything asking for a referral.
post or otherwise publish any content unrelated to the board or the board's topic.
re-post premium share chat posts on regular share chat.
restrict or inhibit any other user from using the boards.
impersonate any person or entity, including any of our employees or representatives.
post or transmit any content that contains software viruses, files or code designed to interrupt, destroy or limit the functionality of this website or any computer software or equipment.
If you are going to post non-English, please also post an English translation of your post.
If you are going to post non-English, please also post an English translation of your post.
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium and Verified Members
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Tommy I hope you’ve had enough answers to satisfy your curiosity. Reddit is the place to find the in-depth answers about what the drug does and why so many on here are relaxed about the future, and you clearly have your own ideas anyway so plenty to build on. Best of luck if you decide to invest.
Mr_Big your first response here made me literally lol, thanks for that! And I take your point - I won't take any legal advice I read here without a dollop of salt, but it's still interesting to read people's thoughts on the matter.
Docdaneeka - why is it suspicious? I "jump on at the weekend" because guess what, that's when I have free time, and this share just recently caught my eye. I "start 2 guaranteed punch up threads" because I'm hoping to understand some of the thorny issues that are extremely pertinent to making an investment in this share. As the responses to the threads show, opinions are still divided, and seeing the different opinions and justifications for them has actually been helpful for me.
It winds me up no end that anyone asking valid questions about a company / investment thesis gets immediately shouted down by the masses.
If your point is that these questions have alreay been asked and answered on this forum, then fair enough - unfortunately LSE doesn't have a good search functionality to go back through old threads to try to find interesting information. But actually, the investment thesis here depends heavily on the pandemic, which is a fast moving situation, so revisitng "answered" questions can still be helpful. And if this forum isn't about answering these questions as they come up, then what is it for exactly? Copy-pasting RNSs and talking into an echo chamber??
Both of these Tommy threads are highly suspicious. Jump on at the weekend and start 2 guaranteed punch up threads. One of which is the particular baby of the board’s longest standing troll - who will come out of his cave soon enough. Let them both die. Tommy can dhor
What people forget is First you’ve got to create your medical treatment Then you’ve got to get it tested Then approved Synairgen are 90% of the way there and they’ve got an already accepted patent. If you want to enter a marathon when the leaders are already in the final 100m go for it but don’t expect to be on the winner’s podium
Mrbig, you've managed a looney tunes theories if sng works but ironically your brain doesn't seem big enough to follow it through to looney tunes theories like France buying the right to manufacture, for use in France only, for £50billion and then every other country doing the same.
You see anyone can make a looney story up, and some nutters actually believe the stories.
Watch those chemtrails increase over the next 2 years, they're coming to get you biggy.
Mr Big - there is a selection of IP in play some of it is pending some of it is already approved and has been for a long time.
When a poster shows up and questions if a patent will get approval and gives two reasons, is it not right that we politely point out that the company has an approved patent already that makes the same claims that they where point out.
Namely IFN and nebulisation.
No one is claiming that the IP is bullet proof but it at least serves the purpose of making any competitors go the long way round and develop their own formulation and gather their own trial data.
Tommy - a blinkered cult-infested gambler forum is a wrong place to ask about complex legal issues. There is currently a patent pending (approved?), however, personally, I am not 100% sure how far it can reach. E.g. Case 1: The French rip off the SNG juice formula and start making and selling it much cheaper than SNG. This looks like an outright patent violation, but even in a "clear-cut" case like this, does SNG have the funds to take on the French/EU Government? If the EU benefits greatly from it, the whole thing might become political very quickly. Also, imagine SNG's publicity if they are taking another company to court to stop them saving lives, because by saving lives they are taking a few quid off the SNG's P&L bottom line. Case 2: France (or Argentina) develop their own formula that works almost as well and start making and selling it at a fraction of SNG's pie-in-the-sky £3k per treatment. SNG can only produce 50k treatments a month, all of them going to the UK and US, so the French are not cutting into SNG sales. Can SNG claim damages when they are not actually suffering any direct financial loss from it (i.e. SNG's sales of 50k treatments a month are still 50k and only limited by the manufacturing capacity. Afaik, if there's no loss, there's no case but wtfdik. Also, publicity again. SNG can't produce enough juice and don't want anyone else producing more to save lives. Case 3: I wouldn't be surprised if more than half of the world's population is in countries that don't care much for SNG's IP and will be making knock-off Chinairgen copies anyway. Then the UK governement will buy Chinairgen instead because it's cheaper - just like they did with covid tests.
Anyone telling you SNG IP is completely, 100% risk-free is a brainwashed idiot.
PS All of the above assumes that - SNG actually works - read the last RNS and make your own conclusions. - SNG can actually manufacture thousands of treatments per month. This has not been the case up until now and there is no update from the company on this.
A medical use claim can also be directed to specific uses of known substances or compositions for the new treatment of the same disease, and novelty and inventive step established by reciting new and inventive routes of administration and novel sub-groups of patients. Inhaled Interferon beta for lower respiratory infection is the basis of their “novel” patents
If you look at Synairgen’s influenza patent it’s based on the type of illness, time of administration, method of administration and type of treatment. So a combination of various elements. If that was not patentable then it would not have been approved, but it was. So it’s possible.
When it comes to covid-19 you have a pending patent and so the details of what was attempted to be patented are not known, but you should deem it as an approved patent until it’s approved/declined. Normally a 12 month process.
You’ll be able to get a reverse-engineered Chinese copy on Amazon in July Tommy. Company based in Guangdong - Sinijen - using ahrojen nebulisers to deliver their Ifn b1a formulation of Esengee. 15 nicker the box
Tommy - Well a competitor would have to create their own formulation to deliver a stable dose of IFN to the lungs. Once they’ve achieved that they would have to push it through a full range of clinical trials to seek approval, which takes years.
So at the very least SNG’s patent ensures any competition have to take the long route and cannot simply copy.
No games, I'm just ignorant about this stuff. I tried to make that clear in my original post.
Trying to understand these things before making a potentially risky investment seems like a reasonable use of my time.
You could accuse me of being lazy - asking these questions on a forum rather than trying to bone up on patent law - and that's fair. Was just hoping someone could help!
And to be honest my question is still relevant. How "specific" is their "specific formulation"? Would their patent prevent any other company from making a nebulised form of IFN? If so then great; if not, that's worth knowing.